Later in vitro studies supported SphK1 modulation of proinflammation in HNSCC cell lines through S1P/interleukin-6 (IL6)- and S1P1/ERK STAT3 signalling [101]. The gene discussed is SPHK1; the disease is head and neck squamous cell carcinoma.